| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.005 | 1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |